M Salsali, E E Cliffton. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adenocarcinoma/complicationsAdenocarcinoma, Bronchiolo-Alveolar/complicationsAdultAgedAutopsyBiopsyCarcinoma, Bronchogenic/complicationsCarcinoma, Squamous Cell/complicationsFemaleFibrinolysin/therapeutic useHumansLung Neoplasms/complicationsMaleMechlorethamine/therapeutic useMiddle AgedNeoplasm MetastasisNeoplasms, Vascular Tissue/complicationsNeoplasms, Vascular Tissue/diagnosisNeoplasms, Vascular Tissue/drug therapyNeoplasms, Vascular Tissue/mortalityNeoplasms, Vascular Tissue/radiotherapyNeoplasms, Vascular Tissue/surgeryVascular Diseases/complicationsVascular Diseases/diagnosisVascular Diseases/drug therapyVascular Diseases/mortalityVascular Diseases/radiotherapyVascular Diseases/surgeryVena Cava, Superior
Substances: See more » MechlorethamineFibrinolysin
Year: 1968 PMID: 4316800 DOI: 10.1016/s0003-4975(10)66050-x
Source DB: PubMed Journal: Ann Thorac Surg ISSN: 0003-4975 Impact factor: 4.330